Opioid maker agrees to pay $225M to settle federal probes
An opioid manufacturer has agreed to pay $225 million to resolve federal investigations into allegations that it paid kickbacks and used other illegal marketing tactics to sell a powerful fentanyl spray, authorities said Wednesday. The settlement stems from criminal and civil probes into Insys Therapeutics Inc.'s scheme to pay doctors in ...
End of content
No more pages to load